11B. IUSTI: Cross Track: Sexually transmitted infection screening in pregnancy - Emerging global evidence from trials of interventions to prevent adverse birth outcomes
Tracks
Track 2
Wednesday, September 18, 2024 |
2:00 PM - 3:30 PM |
Pyrmont Theatre |
Details
Chairs:
Nicola Low, University of Bern
Andrew Vallely, UNSW
Emerging global evidence from trials of interventions to prevent adverse birth outcomes
Nicola Low, University of Bern
Andrew Vallely, UNSW
Emerging global evidence from trials of interventions to prevent adverse birth outcomes
Speaker
Dr Chido Dziva Chikwari
Assistant Professor
London School of Hygiene and Tropical Medicine
The Promise Trial
3:00 PM - 3:10 PMBiography
Chido is an epidemiologist with experience developing, coordinating, and evaluating implementation research studies with particular focus on projects evaluating the provision of sexual and reproductive health services for adolescents and young people in facility and community-based settings.
Dr Lisa Vallely
Senior Research Fellow
Kirby Institute, UNSW
Global epidemiology of STIs in pregnancy and adverse maternal and perinatal health outcomes
2:00 PM - 2:15 PMBiography
As a midwife and public health researcher, Lisa has more than 20 years’ experience living and working in low-resource settings. Her current program of research in Papua New Guinea seeks to improve maternal and newborn health outcomes through the design, implementation and evaluation of clinical and community-based interventions.
Mr William Pomat
Speaker
Unsw/aphp
Point-of-care testing and treatment of STIs in pregnancy to improve birth outcomes in Papua New Guinea: findings of the WANTAIM trial
2:15 PM - 2:30 PMBiography
Ms Mandisa Mdingi
Research Manager
Foundation for Professional Development
Point-of-care STI testing and treatment in pregnancy to improve birth outcomes in South Africa: a randomized‑controlled hybrid effectiveness trial
2:30 PM - 2:45 PMBiography
Mandisa Mdingi, RN, MPH, leads the STI research at the Foundation for Professional Development, East London. Awarded for best oral presentation at the 2023 ISSTDR in Chicago. Pursuing a PhD at the University of Pretoria titled “Molecular epidemiology and antimicrobial resistance of Chlamydia trachomatis and Neisseria gonorrhoeae in South Africa”.
Dr Cheng Wang
None
SMU Institute of Global Health/Dermatology Hospital of SMU/Guangdong Provincial STD Control Center
Chlamydia test and treat strategy to prevent adverse pregnancy outcomes in China: a randomized controlled trial
2:45 PM - 3:00 PMBiography
Dr. Cheng Wang, MD, PhD, is an epidemiologist with an emphasis on promoting HIV/STD related healthy behavior change in high-risk population, particularly those in resource-limited settings. Specifically, his current research focuses on investigating the feasibility and acceptability of promoting syphilis self-testing and dosycyline as PEP to prevent STI in MSM.
IUSTI World Congress
Q&A and Panel Discussion
3:00 PM - 3:30 PMBiography
Dr Lisa Vallely
Senior Research Fellow
Kirby Institute, UNSW
Panelist
Biography
As a midwife and public health researcher, Lisa has more than 20 years’ experience living and working in low-resource settings. Her current program of research in Papua New Guinea seeks to improve maternal and newborn health outcomes through the design, implementation and evaluation of clinical and community-based interventions.
Mr William Pomat
Speaker
Unsw/aphp
Panelist
Biography
Ms Mandisa Mdingi
Research Manager
Foundation for Professional Development
Panelist
Biography
Mrs. Mandisa Mdingi, Professional Nurse and emerging STDs/HIV/AIDS researcher, holds a Master of Public Health. Leading STI projects at the Foundation for Professional Development, she's pursuing a PhD in medical microbiology at the University of Pretoria. Passionate about healthcare, she aims to advance knowledge and treatment in infectious diseases.
Dr Cheng Wang
None
SMU Institute of Global Health/Dermatology Hospital of SMU/Guangdong Provincial STD Control Center
Panelist
Biography
Dr. Cheng Wang, MD, PhD, is an epidemiologist with an emphasis on promoting HIV/STD related healthy behavior change in high-risk population, particularly those in resource-limited settings. Specifically, his current research focuses on investigating the feasibility and acceptability of promoting syphilis self-testing and dosycyline as PEP to prevent STI in MSM.
Dr Remco Peters
Medical Officer
World Health Organization
Panelist
Biography
Dr Peters leads the STI care and treatment programme at the WHO since this year. He has almost 20 years’ experience working as clinician, epidemiologist, and researcher in the STI and HIV fields in low-resource settings across Southern Africa.
Chair
Nicola Low
Professor of Epidemiology And Public Health
University of Bern
Andrew Vallely
Head, Global Reproductive Health
University Of New South Wales
